Gilde Healthcare is a specialized European healthcare investor founded in 1982 and based in Utrecht, managing over €2.6 billion across two fund strategies: Venture & Growth (medtech, diagnostics, digital health, therapeutics) and Private Equity (lower mid-market healthcare companies in North-Western Europe). In 2025, Gilde's Private Equity arm made parallel acquisitions of Artinis Medical Systems (Netherlands) and NIRx Medical Technologies (Germany/US) — two leading pioneers in functional Near-Infrared Spectroscopy (fNIRS) neuroimaging — combining them into a new global neuroimaging platform. This transaction establishes Gilde as a significant strategic holder in brain imaging tools for academic neuroscience. The Venture & Growth fund has also backed Big Health (digital mental health therapeutics) across multiple rounds. Gilde invests across Europe and North America.